Research Insight
Novartis drug Afinitor® reduces seizures patients with tuberous sclerosis...
Novartis announced results from a Phase III study showing Afinitor®* (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures associated with tuberous sclerosis...
Research Insight
AbbVie, CytomX to co-develop for Probody Drug Conjugates
AbbVie and CytomX Therapeutics, Inc announced that they have entered into a collaboration to co-develop and co-commercialize Probodyâ„¢ Drug Conjugates against CD71, also known...
Research Insight
OFIRMEV (Acetaminophen) Injection Health Economic Data Presented and Specially...
Mallinckrodt plc a leading global specialty biopharmaceutical company announced the results from a retrospective analysis of health economic data on the use of OFIRMEV (acetaminophen)...
Research Insight
Teva announced new data from the Phase III placebo-controlled...
Teva Pharmaceutical Industries Ltd., announced new data from the Phase III placebo-controlled and randomized First Time Use of SD-809 in HuntingtonDisease (First-HD) study evaluating the...
Research Insight
IMS Health Study: U.S. Drug Spending Growth Reaches 8.5...
Total spending on medicines in the U.S. reached $310 billion in 2015 on an estimated net price basis, up 8.5 percent from the previous year,...
Research Insight
Amgen, UCB Present reports on comparing Romosozumab With Teriparatide
In Phase 3 Open-Label STRUCTURE Study Postmenopausal Women With Osteoporosis Transitioning From Oral Bisphosphonates to Romosozumab Experienced Consistent and Significant Gains in Bone Mass and...
Research Insight
The diabetes drug pioglitazone is associated with an increased...
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, finds a study published by The BMJ today. The findings suggest that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.